PURE Bioscience, Inc.
PURE
$0.0688
$0.013825.09%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.78% | 15.43% | 12.88% | 9.91% | -0.41% |
| Total Depreciation and Amortization | -10.48% | 26.50% | -18.30% | -27.06% | -32.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.48% | -59.29% | -27.38% | -27.60% | 2.76% |
| Change in Net Operating Assets | 270.21% | 471.03% | 316.67% | 535.71% | -12.96% |
| Cash from Operations | 7.88% | 22.79% | 14.50% | 11.33% | -2.62% |
| Capital Expenditure | -- | -- | 146.24% | 106.15% | 106.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 146.24% | 106.15% | 106.25% |
| Total Debt Issued | -16.67% | 75.86% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -16.67% | 75.86% | -34.29% | -48.57% | -48.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.10% | 67.51% | -225.56% | -362.15% | -246.24% |
